Center for Scientific Review; Notice of Closed Meetings, 14475-14476 [E8-5206]

Download as PDF Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices Date: April 10, 2008. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Rm 3119, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Ileana M. Ponce-Gonzalez, MD, MPH, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451– 3679, ipgonzalez@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–5210 Filed 3–17–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of General Medical Sciences Special Emphasis Panel, March 28, 2008, 8 a.m. to March 28, 2008, 5 p.m., Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD, 20814 which was published in the Federal Register on March 6, 2008, 73 FR 12184. The meeting will be held on March 28, 2008 from 10 a.m. to 3 p.m. The meeting is closed to the public. Dated: March 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–5218 Filed 3–17–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on PROD1PC66 with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Office of AIDS Research Advisory Council. VerDate Aug<31>2005 17:39 Mar 17, 2008 Jkt 214001 The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Office of AIDS Research Advisory Council. Date: April 17, 2008. Time: 9 a.m. to 5 p.m. Agenda: Discussions will focus on Genetics of HIV Infection and Human Immunology: Leveraging Genetics and Genomics Resources for the Study of HIV/ AIDS. An update on the OARAC Working Groups for Treatment and Prevention Guidelines. Place: National Institutes of Health 5635 Fishers Lane, MSC 9310 Suite 4000 Rockville, MD 20852. Contact Person: Christina Brackna, Coordinator, Program Planning and Analysis, Office of AIDS Research, Office of the Director, NIH 5635 Fishers Lane, MSC 9310, Suite 4000, Rockville, MD 20852, (301) 402– 8655, cm53v@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nih.gov/od/oar/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: March 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–5318 Filed 3–17–08; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 14475 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Urology Small Business and Study Section Conflicts. Date: April 2, 2008. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Shirley Hilden, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 20892, (301) 435– 1198, hildens@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Hematopoiesis. Date: April 3, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Delia Tang, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4126, MSC 7802 Bethesda, MD 20892, 301–435–2506, tangd@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Stem Cells, Progenitors and Signaling. Date: April 3, 2008. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jonathan K. Ivins, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD 20892, (301) 594– 1245, ivinsj@csr.nih.gov. E:\FR\FM\18MRN1.SGM 18MRN1 14476 Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices Name of Committee: Oncological Sciences Integrated Review Group Clinical Oncology Study Section. Date: May 19–20, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sharon K. Gubanich, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 20892, (301) 435– 1767, gubanics@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group Macromolecular Structure and Function E Study Section. Date: May 27–28, 2008. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: La Jolla Shores Hotel, 8110 Camino del Oro, La Jolla, CA 92037. Contact Person: Nitsa Rosenzweig, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1102, MSC 7760, Bethesda, MD 20892, (301) 435– 1747, rosenzweign@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–5206 Filed 3–17–08; 8:45 am] National Cancer Institute; Call for Nominations for the National Cancer Institute Director’s Consumer Liaison Group National Institutes of Health mstockstill on PROD1PC66 with NOTICES Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Institutes of Health Peer Review Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Institutes of Health Peer Review Advisory Committee. Date: April 30, 2008. Time: 8:30 a.m. to 5 p.m. Agenda: Provide technical and scientific advice to the Director, National Institutes of Jkt 214001 BILLING CODE 4140–01–M National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES 17:39 Mar 17, 2008 Dated: March 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–5212 Filed 3–17–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M VerDate Aug<31>2005 Health (NIH), the Deputy Director for Extramural Research, NIH and the Director, Center for Scientific Review (CSR), on matters relating broadly to review procedures and policies for the evaluation of scientific and technical merit of applications for grants and awards. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Ballroom Level, Bethesda, MD 20814. Contact Person: Cheryl A. Kitt, PhD, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 20892, 301–435– 1112, kittc@csr.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) The National Cancer Institute (NCI), the Federal Government’s primary agency for cancer research, is seeking nominations for up to six (6) new members of the NCI Director’s Consumer Liaison Group (DCLG) who will be appointed in July 2008. The DCLG is a Federal chartered advisory committee of the NCI. It consists of 16 consumer advocates who are involved in cancer advocacy and who reflect the diversity among those whose lives are affected by cancer. The mission of the DCLG is to advise, assist, consult with, and make recommendations to the NCI Director, from the perspective and viewpoint of cancer consumer advocates on a wide variety of issues, programs, and research priorities. The DCLG serves as a channel for consumer advocates to voice their views and concerns. Specifically, the DCLG members: • Help develop and establish processes, mechanisms, and criteria for PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 identifying appropriate consumer advocates to serve on a variety of program and policy advisory committees responsible for advancing the mission of the NCI. • Serve as a primary forum for discussing issues and concerns and exchanging viewpoints that are important to the broad development of the NCI programmatic and research priorities. • Establish and maintain strong collaborations between the NCI and the cancer advocacy community to reach common goals. Eligibility Requirements for Individual Members: To serve on the DCLG, a member must meet the following minimum eligibility requirements: • Be involved in the cancer experience as a cancer survivor, a caregiver to someone who has cancer, or a professional or volunteer who works with survivors or those affected by cancer; and • Represent a constituency with whom you communicate regularly on cancer issues and be able to serve as a conduit for information both to and from your constituency. DCLG members must be committed to participate fully in all activities of the DCLG, including at least two meetings per year in the Bethesda, MD area, conference calls, and working group activities. Criteria for Evaluating Individual Candidates: Nominees who meet the minimum eligibility requirements will be further assessed based on the following criteria: • Cancer advocacy experience; • Possession of strong leadership skills; • Communication and collaboration skills; • Ability to represent/advise on broad, cross-cutting cancer issues, including those NCI priorities identified by the NCI Director; • Ability to facilitate dialogue between NCI and the cancer advocacy community. Characteristics of the DCLG: In addition to the criteria for individual candidates, the following characteristics of the DCLG as a group are intended to ensure that it reflects the breadth and diversity of the consumer advocacy community: • Ethnic and cultural diversity; • A broad mix of cancer sites; • Representation of the medically underserved; • A range of cancer advocacy organizations (from small, local to regional and national); • A diversity of ages and gender; • Geographic diversity (including urban/rural areas). E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Notices]
[Pages 14475-14476]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Urology Small Business and Study Section Conflicts.
    Date: April 2, 2008.
    Time: 11 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Shirley Hilden, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 20892, (301) 435-
1198, hildens@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Hematopoiesis.
    Date: April 3, 2008.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4126, MSC 7802 Bethesda, MD 20892, 301-435-
2506, tangd@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Stem Cells, Progenitors and Signaling.
    Date: April 3, 2008.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jonathan K. Ivins, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD 
20892, (301) 594-1245, ivinsj@csr.nih.gov.


[[Page 14476]]


    Name of Committee: Oncological Sciences Integrated Review Group 
Clinical Oncology Study Section.
    Date: May 19-20, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Sharon K. Gubanich, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 
20892, (301) 435-1767, gubanics@csr.nih.gov.

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group Macromolecular Structure and 
Function E Study Section.
    Date: May 27-28, 2008.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: La Jolla Shores Hotel, 8110 Camino del Oro, La Jolla, CA 
92037.
    Contact Person: Nitsa Rosenzweig, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1102, MSC 7760, Bethesda, MD 
20892, (301) 435-1747, rosenzweign@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-5206 Filed 3-17-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.